(Q73224740)
Statements
Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets (English)
Songia S
Mortellaro A
Taverna S
Fornasiero C
Scheiber EA
Erba E
Colotta F